Clinical trials
Phase 1 Respiratory Tract Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blueprint Medicines Corporation | 3 |
| Revolution Medicines, Inc. | 3 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Emergent BioSolutions | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Lisata Therapeutics, Inc. | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Stony Brook University | 1 |
| Syndax Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Tract Diseases | 14 |
| Lung Diseases | 10 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Lung Neoplasms | 8 |
| Neoplasms | 8 |
| Neoplasms by Site | 8 |
| Respiratory Tract Neoplasms | 8 |
| Thoracic Neoplasms | 8 |
| Bronchial Neoplasms | 7 |
| Carcinoma, Bronchogenic | 7 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.